CRO – Contract Research Organization: How Drug Research is Evolving: How Drug Research is EvolvingAnchor Academic Publishing (aap_verlag), 2014 M02 1 - 90 páginas This book deals in general with mergers & acquisitions in the CRO industry, and more specifically with reasons for M&A, success factors during the M&A process, and why M&A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new medications. That has to do with stricter requirements for admission and sharper controls by authorities. Today, the research and development of a new drug can easily consume more than $800 million and lasting between 10 and 15 years. Due to these facts pharmaceutical companies are looking for an alternative in the drug development process. A popular alternative is the outsourcing or in-house working with Contract Research Organizations (CRO). CRO are specialized in coordination and monitoring of drug development activities. The size of the CRO market in 2012 was around $32 billion and had an estimated market growth of around 9 – 12% for 2013. Increased outsourcing and allocation of R&D money towards CRO reflects a driving force for prospective growth. Contract Research Organizations consider mergers & acquisitions as a vital solution to achieve their objectives. |
Contenido
vii | |
viii | |
ix | |
11 | |
12 | |
13 | |
2 Contract Research Organization Industry | 20 |
3 Explanatory Approaches and Motives for MA | 35 |
4 Success Factors for the Merger Acquisitions process | 42 |
5 Case Study Merger Acquisitions in the CRO industry | 56 |
6 Conclusion and Recommendations | 68 |
Appendix | 61 |
Bibliography | 73 |
Otras ediciones - Ver todas
Cro - Contract Research Organization: How Drug Research Is Evolving Jakob Miera Sin vista previa disponible - 2014 |
Términos y frases comunes
academic According acquirer activities Additionally analysis approach average changes chapter clinical trials collaboration communication competitive completed conduct Contract Research Organizations corporations costs countries create CRO industry cultural customers deal departments determine drug development due diligence Economic effect employees entire estimated evaluation execution phase failures Figure final firms future geographical global goals growth higher identify important increase influence integration integration phase International involved Journal literature M&A process mentioned merger wave Mergers & Acquisitions Mergers and Acquisitions Moreover motives operating Particularly pharmaceutical phase planning phase political possible potential reasons Potential Success Factors ranked reasons relatively role screening share situation specific stage Strategic Alliances strategic planning structure survey Synergy Table takeover Taking tion transaction University valuation